Condition: Myocardial Infarction · Sponsor: Novo Nordisk A/S
The study is testing the effect of ziltivekimab on reducing plaque in the blood vessels of the heart, specifically aiming to manage or reduce atherosclerotic plaque. The purpose of the study is to determine whether ziltivekimab can effectively reduce this plaque. Participants will either receive ziltivekimab (the active medicine) or a placebo (a dummy medicine with no effect on the body), with the treatment assignment decided by chance. It is important to note that ziltivekimab is not yet approved in any country or region worldwide; therefore, it is a new medicine that doctors cannot prescribe. The study will last for about 15 months.
This description comes directly from the study's public registry record.
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
| Medizinische Universität Wien | Vienna, Austria | Not Yet Recruiting |
| Aalborg Universitetshospital Hjertemedicinsk Afdeling | Gistrup, Denmark | Not Yet Recruiting |
| Rigshospitalet - Kardiologisk Forskningsenhed | København Ø, Denmark | Not Yet Recruiting |
| Azienda Ospedaliera San Giovanni Addolorata | Rome, Lazio, Italy | Not Yet Recruiting |
| Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII | Bergamo, Lombardy, Italy | Not Yet Recruiting |
| DAI Scienze Mediche - UOC Endocrinologia | Messina, Sicily, Italy | Not Yet Recruiting |
| Presidio Ospedaliero di Rivoli | Rivoli, To, Italy | Not Yet Recruiting |
| Ospedale Policlinico San Martino | Genova, Italy | Not Yet Recruiting |
| AOU Maggiore della Carità di Novara - Dipartimento Toraco-Cardio-Vascolare - SCDU Cardiologia | Novara, Italy | Not Yet Recruiting |
| Azienda Ospedaliera Universitaria San Luigi Gonzaga - S.C.D.O. Microcitemie e malattie rare ematologiche | Orbassano, Italy | Not Yet Recruiting |
| Fondazione Policlinico Universitario Agostino Gemelli IRCS | Rome, Italy | Not Yet Recruiting |
| IRCCS Policlinico San Donato | San Donato Milanese, Italy | Not Yet Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07301034